US Stock MarketDetailed Quotes

RMTI Rockwell Medical

Watchlist
  • 3.6500
  • +0.0100+0.27%
Close Oct 7 16:00 ET
  • 3.6000
  • -0.0500-1.37%
Post 20:01 ET
113.26MMarket Cap-24333P/E (TTM)

Rockwell Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
42.88%25.83M
15.29%22.68M
14.84%83.61M
14.39%22.09M
27.18%23.77M
-3.22%18.08M
21.98%19.67M
17.57%72.81M
25.97%19.31M
16.91%18.69M
Operating revenue
42.88%25.83M
15.29%22.68M
14.84%83.61M
14.39%22.09M
27.18%23.77M
-3.22%18.08M
21.98%19.67M
17.57%72.81M
25.97%19.31M
16.91%18.69M
Cost of revenue
24.84%21.28M
14.90%19.61M
8.98%74.91M
13.26%19.22M
20.40%21.57M
0.65%17.05M
0.94%17.07M
6.81%68.73M
-3.36%16.97M
9.79%17.91M
Gross profit
340.46%4.55M
17.89%3.06M
113.49%8.7M
22.65%2.87M
183.40%2.2M
-40.80%1.03M
430.66%2.6M
268.47%4.08M
204.89%2.34M
336.17%777K
Operating expense
1.08%4.04M
8.99%4.39M
-26.29%15.37M
-20.65%3.42M
-12.17%3.94M
-35.89%3.99M
-31.06%4.03M
-25.29%20.86M
-29.73%4.31M
-32.49%4.49M
Selling and administrative expenses
5.49%4.04M
16.60%4.37M
-19.57%14.27M
-21.71%3.25M
-14.22%3.45M
-27.84%3.83M
-12.29%3.75M
-15.86%17.74M
-12.41%4.15M
-25.93%4.02M
-Selling and marketing expense
10.57%586K
19.28%594K
1.48%2.13M
54.13%541K
-27.03%556K
0.76%530K
9.45%498K
-63.47%2.09M
-59.79%351K
-50.55%762K
-General and administrative expense
4.67%3.45M
16.18%3.78M
-22.39%12.14M
-28.72%2.71M
-11.22%2.89M
-30.99%3.3M
-14.88%3.25M
1.93%15.64M
-1.71%3.8M
-16.16%3.25M
Research and development costs
--0
-93.53%18K
-64.51%1.11M
7.69%168K
5.33%494K
-81.97%167K
-82.26%278K
-54.37%3.12M
-88.78%156K
-61.59%469K
Operating profit
117.40%515K
7.22%-1.32M
60.25%-6.67M
72.18%-547K
53.16%-1.74M
33.98%-2.96M
78.46%-1.43M
44.69%-16.78M
76.48%-1.97M
46.82%-3.71M
Net non-operating interest income expense
35.55%-223K
-26.01%-407K
-9.83%-2.09M
-169.19%-1.07M
26.35%-355K
28.66%-346K
40.19%-323K
18.61%-1.9M
32.08%-396K
20.85%-482K
Non-operating interest income
-81.63%9K
-62.50%24K
539.39%211K
--42K
--56K
--49K
--64K
50.00%33K
----
----
Non-operating interest expense
-41.27%232K
11.37%431K
18.85%2.3M
158.28%1.11M
-14.73%411K
-18.56%395K
-28.33%387K
-17.97%1.94M
-27.04%429K
-20.85%482K
Other net income (expense)
51K
7,925.00%321K
101K
220K
4K
0
Gain on sale of security
--51K
----
7,925.00%321K
--101K
--220K
----
----
--4K
--0
----
Income before tax
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
44.73%-4.19M
Income tax
Net income
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
44.73%-4.19M
Net income continuous Operations
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
44.73%-4.19M
Minority interest income
Net income attributable to the parent company
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
44.73%-4.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
110.38%343K
1.09%-1.73M
54.82%-8.44M
35.99%-1.51M
55.32%-1.87M
33.46%-3.31M
75.57%-1.75M
42.83%-18.68M
73.58%-2.36M
44.73%-4.19M
Basic earnings per share
105.56%0.01
40.00%-0.06
71.76%-0.37
75.00%-0.05
69.57%-0.07
58.14%-0.18
88.10%-0.1
65.80%-1.31
80.77%-0.2
74.16%-0.23
Diluted earnings per share
105.56%0.01
40.00%-0.06
71.76%-0.37
75.00%-0.05
69.57%-0.07
58.14%-0.18
88.10%-0.1
65.80%-1.31
80.77%-0.2
74.16%-0.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 42.88%25.83M15.29%22.68M14.84%83.61M14.39%22.09M27.18%23.77M-3.22%18.08M21.98%19.67M17.57%72.81M25.97%19.31M16.91%18.69M
Operating revenue 42.88%25.83M15.29%22.68M14.84%83.61M14.39%22.09M27.18%23.77M-3.22%18.08M21.98%19.67M17.57%72.81M25.97%19.31M16.91%18.69M
Cost of revenue 24.84%21.28M14.90%19.61M8.98%74.91M13.26%19.22M20.40%21.57M0.65%17.05M0.94%17.07M6.81%68.73M-3.36%16.97M9.79%17.91M
Gross profit 340.46%4.55M17.89%3.06M113.49%8.7M22.65%2.87M183.40%2.2M-40.80%1.03M430.66%2.6M268.47%4.08M204.89%2.34M336.17%777K
Operating expense 1.08%4.04M8.99%4.39M-26.29%15.37M-20.65%3.42M-12.17%3.94M-35.89%3.99M-31.06%4.03M-25.29%20.86M-29.73%4.31M-32.49%4.49M
Selling and administrative expenses 5.49%4.04M16.60%4.37M-19.57%14.27M-21.71%3.25M-14.22%3.45M-27.84%3.83M-12.29%3.75M-15.86%17.74M-12.41%4.15M-25.93%4.02M
-Selling and marketing expense 10.57%586K19.28%594K1.48%2.13M54.13%541K-27.03%556K0.76%530K9.45%498K-63.47%2.09M-59.79%351K-50.55%762K
-General and administrative expense 4.67%3.45M16.18%3.78M-22.39%12.14M-28.72%2.71M-11.22%2.89M-30.99%3.3M-14.88%3.25M1.93%15.64M-1.71%3.8M-16.16%3.25M
Research and development costs --0-93.53%18K-64.51%1.11M7.69%168K5.33%494K-81.97%167K-82.26%278K-54.37%3.12M-88.78%156K-61.59%469K
Operating profit 117.40%515K7.22%-1.32M60.25%-6.67M72.18%-547K53.16%-1.74M33.98%-2.96M78.46%-1.43M44.69%-16.78M76.48%-1.97M46.82%-3.71M
Net non-operating interest income expense 35.55%-223K-26.01%-407K-9.83%-2.09M-169.19%-1.07M26.35%-355K28.66%-346K40.19%-323K18.61%-1.9M32.08%-396K20.85%-482K
Non-operating interest income -81.63%9K-62.50%24K539.39%211K--42K--56K--49K--64K50.00%33K--------
Non-operating interest expense -41.27%232K11.37%431K18.85%2.3M158.28%1.11M-14.73%411K-18.56%395K-28.33%387K-17.97%1.94M-27.04%429K-20.85%482K
Other net income (expense) 51K7,925.00%321K101K220K4K0
Gain on sale of security --51K----7,925.00%321K--101K--220K----------4K--0----
Income before tax 110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M44.73%-4.19M
Income tax
Net income 110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M44.73%-4.19M
Net income continuous Operations 110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M44.73%-4.19M
Minority interest income
Net income attributable to the parent company 110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M44.73%-4.19M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 110.38%343K1.09%-1.73M54.82%-8.44M35.99%-1.51M55.32%-1.87M33.46%-3.31M75.57%-1.75M42.83%-18.68M73.58%-2.36M44.73%-4.19M
Basic earnings per share 105.56%0.0140.00%-0.0671.76%-0.3775.00%-0.0569.57%-0.0758.14%-0.1888.10%-0.165.80%-1.3180.77%-0.274.16%-0.23
Diluted earnings per share 105.56%0.0140.00%-0.0671.76%-0.3775.00%-0.0569.57%-0.0758.14%-0.1888.10%-0.165.80%-1.3180.77%-0.274.16%-0.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data